Go to Law360 Home Law360
The Newswire for IP Professionals
Top story picture

UnitedHealth To Settle Options Battles For $912M

Minneapolis-based managed health care company UnitedHealth Group announced Wednesday that it has reached proposed settlement agreements in two lawsuits relating to its stock options practices.

divider graphic

Legal And Regulatory Calendar

Thursday, Jul 03, 2008

Our daily calendar of events lists conferences and hearings scheduled to take place in the next four weeks.

Eli Lilly Drops Glenmark In $500M ADHD Drug Suit

Thursday, Jul 03, 2008

Eli Lilly and Co. agreed to drop patent infringement charges against generics maker Glenmark Pharmaceuticals Inc. USA as long as Glenmark adheres to any future rulings regarding a generic version of Strattera, an Eli Lilly drug used to treat attention deficit hyperactivity disorder.

Pfizer Employee Avoids Prison in Embezzlement Case

Thursday, Jul 03, 2008

Hollis Rosendale, a former executive assistant with pharmaceutical company Pfizer Inc., has avoided jail time but must return close to $130,000 she embezzled from the company.

Michigan Contests BCBS For-Profit Acquisition

Thursday, Jul 03, 2008

State Attorney General Mike Cox has filed a lawsuit against the nonprofit health care company Blue Cross Blue Shield of Michigan, asking that the company be ordered to divest itself of a for-profit company acquired through the State Accident Fund.

Panel Recommends More Testing for Diabetes Drugs

Thursday, Jul 03, 2008

The U.S. Food and Drug Administration should require pharmaceutical companies to conduct studies examining the effect of new diabetes drugs on the heart, an advisory committee recommended Wednesday.

VNUS Sues Three More Rivals Over Laser Treatment

Thursday, Jul 03, 2008

Fresh from a $10 million victory in an infringement case over patents relating to laser treatment of varicose veins, VNUS Medical Technologies Inc. announced Wednesday it is suing three more companies for alleged infringement of the same patents.

Governor Files Amicus Brief In DuPont Appeal

Thursday, Jul 03, 2008

The governor of West Virginia has stepped in on the side of chemical maker E.I. du Pont de Nemours & Co., asking the West Virginia Supreme Court to ensure that the company is granted appropriate review in its appeal of a $196 million punitive damages award in a toxic tort lawsuit.

VA Official Pleads Guilty To Accepting Kickbacks

Wednesday, Jul 02, 2008

A Veterans Affairs official pled guilty on Monday to accepting kickbacks from a supplier in exchange for contracts.

Biotech Cos. Battle Over Forum In Stem Cells Suit

Wednesday, Jul 02, 2008

A Maryland judge will decide which court is best suited to hear a dispute between biotechnology rivals StemCells Inc. and Neuralstem Inc. over patents related to neural stem cell compositions.

Inequitable Conduct Claim Nixed In Seroquel Suit

Wednesday, Jul 02, 2008

Sandoz Inc. and Teva Pharmaceutical Industries Ltd. have lost their bid to render the patent for AstraZeneca Pharmaceuticals LP's popular anti-psychotic drug Seroquel unenforceable, eliminating the need for a trial in the case.

Jury Lets One Fen-Phen Lawyer Off The Hook

Wednesday, Jul 02, 2008

One of three lawyers accused of keeping millions of dollars meant for plaintiffs in a class action settlement over the diet drug fen-phen has been acquitted, but a federal jury is still deliberating on the fate of the two other lawyers.

Drugmakers To Appeal $114M Verdict In AWP Case

Wednesday, Jul 02, 2008

GlaxoSmithKline and Novartis Pharmaceuticals Corp. vowed Wednesday to challenge a $114 million verdict handed down by an Alabama jury, which found the companies had defrauded the state as part of a long-running scam to inflate drug prices.

Pfizer Wins Dismissal Of 4 Claims From Celebrex Suit

Wednesday, Jul 02, 2008

A federal judge has dismissed a handful of claims from a securities class action against Pfizer Inc. over the company’s alleged nondisclosure of studies linking painkillers Celebrex and Bextra to an increased risk of heart attacks and strokes.

Bone Fusing Products Pose Risk, FDA Says

Wednesday, Jul 02, 2008

Bone growth products made by Medtronic Inc. and Stryker Corp. may cause serious complications in neck-bone fusion procedures, the FDA warned physicians Tuesday.

Quintiles Sued Over Drug Data Collection Patent

Tuesday, Jul 01, 2008

Health care software supplier Datasci LLC has filed a patent infringement suit against Quintiles Transnational Corp. over data collection technology used to speed up drug trials.

Bavarian Nordic Sues Oxford BioMedica Over Patents

Tuesday, Jul 01, 2008

A year after Bavarian Nordic settled a global patent feud with Acambis over a smallpox vaccine, the biopharmaceutical company is suing Oxford BioMedica Inc. over patents related to the same virus.

Cardio Access Expands Catheter Patent Suit

Tuesday, Jul 01, 2008

A patent-holding firm has expanded a suit it filed over a catheter patent, naming subsidiaries of original defendants Boston Scientific Corp., Johnson & Johnson and Medtronic Inc., as well as Edwards Lifesciences Corp.

AstraZeneca Sues To Protect Accolate

Tuesday, Jul 01, 2008

Drug manufacturers AstraZeneca UK Limited and AstraZeneca Pharmaceuticals LP have filed a patent infringement lawsuit seeking to prevent Dr. Reddy's Laboratories Ltd. of India from making a generic version of AstraZeneca's asthma treatment drug Accolate.

Plaintiffs Battle For Lead Role In Vytorin ERISA Suit

Tuesday, Jul 01, 2008

The lead plaintiffs in a shareholder lawsuit over Merck & Co. Inc.'s shelved Vioxx painkiller have asked to assume the role of lead plaintiff in a new proposed multidistrict litigation over allegations that the company covered up evidence that its cholesterol drug Vytorin was less effective than advertised.

Judge Strips Claims From Wage Suit Against Insurer

Monday, Jun 30, 2008

Health insurer Blue Cross Blue Shield of Minnesota has won a bid to quash the majority of claims in a wage-and-hour dispute with former employees.

Guest Column
Guest Column picture

Allison Engine: The Presentment Issue Under The FCA

It is unclear whether the Supreme Court's ruling in Allison Engine will ultimately expand or narrow the False Claims Act’s scope given that the court determined that neither side of the circuit split was correct, says Robert J. Wagman Jr. of Baker Botts LLP.

Submit a guest column